Revenue Breakdown
Composition ()
No data
Revenue Streams
Varex Imaging Corp (VREX) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Medical, accounting for 66.4% of total sales, equivalent to $152.10M. Another important revenue stream is Industrial. Understanding this composition is critical for investors evaluating how VREX navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Varex Imaging Corp maintains a gross margin of 33.99%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 8.56%, while the net margin is 5.33%. These profitability ratios, combined with a Return on Equity (ROE) of -13.95%, provide a clear picture of how effectively VREX converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, VREX competes directly with industry leaders such as DRTS and LAB. With a market capitalization of $589.81M, it holds a significant position in the sector. When comparing efficiency, VREX's gross margin of 33.99% stands against DRTS's N/A and LAB's 48.51%. Such benchmarking helps identify whether Varex Imaging Corp is trading at a premium or discount relative to its financial performance.
